Skip to the page

Data / Drug companies / Methenamine, sodium salicylate

Methenamine, sodium salicylate: 17 companies and 20 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Methenamine, sodium salicylate is listed in the FDA National Drug Code Directory by 17 companies, with 20 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, and the newest product started marketing on August 10, 2026.

The request: Get every company that lists methenamine, sodium salicylate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
17
Products
20
Generic (ANDA) products
0 (0.0%)
Application numbers
1
Routes
Oral
Brand names
Quality Choice Antibacterial Plus Urinary Pain Relief, Cystex, Rite Aid Antibacterial Plus Urinary Pain Relief, TopCare Antibacterial Plus Urinary Pain Relief, CVS Dual Action Pain Relief, Walgreens Antibacterial Plus Urinary Pain Relief, Uti Infection Control, Good Neighbor Antibacterial Plus Urinary Pain Relief
openFDA record search
api.fda.gov

Companies that list methenamine, sodium salicylate

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Clarion Brands, LLC3tabletOther unapproved drugsNovember 1, 2024
Walgreen Company2tabletOther unapproved drugsOctober 21, 2024
Amerisource Bergen1tabletOther unapproved drugsNovember 23, 2019
CVS Pharmacy1tabletOther unapproved drugsFebruary 22, 2017
CVS Woonsocket Prescription Center, Incorporated1tabletOther unapproved drugsOctober 16, 2024
Cadence Health, Inc.1tabletOther unapproved drugsApril 6, 2026
Chain Drug Consortium, LLC1tabletOther unapproved drugsFebruary 22, 2017
Chain Drug Marketing Association1tabletOther unapproved drugsFebruary 22, 2017
Chain Drug Marketing Association, Inc.1tabletOther unapproved drugsDecember 2, 2025
Meijer Distribution Inc1tabletOther unapproved drugsFebruary 22, 2017
Nuvicare LLC1tabletOther unapproved drugsAugust 10, 2026
Pioneer Life Sciences, LLC1tabletOther unapproved drugsAugust 10, 2026
Reese Pharmaceutical Co1tabletOther unapproved drugsFebruary 22, 2017
Rising Pharma Holdings, Inc.1tabletOther unapproved drugsDecember 6, 2023
Rite Aid Corporation1tabletOther unapproved drugsFebruary 22, 2017
Topco Associates LLC1tabletOther unapproved drugsFebruary 22, 2017
i-Health, Inc.1tabletOther unapproved drugsNovember 6, 2015

Dosage forms

Dosage formProductsShare
Tablet20100%

Marketing categories

Marketing categoryProductsShare
Other unapproved drugs1995%
Over the counter monograph drugs15%

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.